ImmunityBio (IBRX) Amortizatization of Intangibles (2015 - 2026)
ImmunityBio (IBRX) reported Amortizatization of Intangibles of $1.5 million for Q1 2026, up 2834.62% year-over-year from $52000.0 in Q1 2025, and down 10.45% quarter-over-quarter from $1.7 million in Q4 2025.
ImmunityBio (IBRX) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 12 years of Amortizatization of Intangibles data on file, last reported at $1.5 million in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $1.5 million, up 2834.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 million (up 301.81% YoY), and the FY2025 annual result was $2.7 million, up 84.35% from the prior year.
- Amortizatization of Intangibles fell to $1.5 million in Q1 2026 per IBRX's latest filing, from $1.7 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $7.2 million in Q4 2022 and troughed at -$4.6 million in Q4 2023.
- A 5-year average of $695823.5 and a median of $580000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2025: Amortizatization of Intangibles sank 31615.38% in 2022, then jumped 7000.0% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $7.2 million in 2022, then sank by 164.12% to -$4.6 million in 2023, then jumped by 100.52% to $24000.0 in 2024, then jumped by 7000.0% to $1.7 million in 2025, then dropped by 10.45% to $1.5 million in 2026.
- Business Quant data shows IBRX's Amortizatization of Intangibles at $1.5 million in Q1 2026, $1.7 million in Q4 2025, and $978000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | 1.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.53 Mn |
| Mar 31, 2026 | 1.53 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | 978,000.00 |
| Sep 30, 2025 | 978,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | 580,000.00 |
| Sep 30, 2024 | 580,000.00 |
| Jun 30, 2024 | 394,000.00 |
| Jun 30, 2024 | 394,000.00 |
| Mar 31, 2024 | 491,000.00 |
| Mar 31, 2024 | 491,000.00 |
| Dec 31, 2023 | -4.65 Mn |
| Dec 31, 2023 | -4.65 Mn |